FrancesA.The new crisis in confidence in psychiatric diagnosis. Ann Intern Med. 2013;159(3):221–222. Pre-published online 2013 May 27. Available from: http://annals.org/article.aspx?articleid=1688399.
LeuchtSHierlSKisslingW, Putting the efficacy of psychiatric and general medicine medication into perspective: Review of meta-analyses. Br J Psychiatry. 2012;200:97–106.
4.
MeyersBSSireyJABruceM, Predictors from early recovery from major depression among people admitted to community-based clinics. Arch Gen Psychiatry. 2002;59:729–735.
5.
AlexopoulosGSKatzIRBruceML, Remission in depressed geriatric primary care patients: A report from the PROSPECT study. Am J Psychiatry. 2005;162:718–724.
6.
SimonGEHeiligensteinJHGrothausL, Should anxiety and insomnia influence antidepressant selection: A randomized comparison of fluoxetine and imipramine. J Clin Psychiatry. 1998;59:49–55.
7.
GartlehnerGHansenRAMorganLC, Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Ann Intern Med. 2011;155:772–785.
8.
FabbriCPorcelliSSerrettiA.From pharmacogenetics to pharmacogenomics: The way toward the personalization of antidepressant treatment. Can J Psychiatry. 2014;59(2):62–75.
9.
BrandlEJKennedyJLMüllerDJ. Pharmacogenetics of antipsychotics. Can J Psychiatry. 2014;59(2):76–88.